Vallianatou G N, Douladiris N, Mageiros L, Manousakis E, Zisaki V, Galani M, Xepapadaki P, Taka S, Papadopoulos N G
Allergy Department, 2nd Pediatric Clinic, National and Kapodistrian University of Athens, Athens, Greece.
Department of Information Technology and Biomedical Sciences, The American College of Greece, Athens, Greece.
Pediatr Allergy Immunol. 2024 Dec;35(12):e70008. doi: 10.1111/pai.70008.
Food protein-induced allergic proctocolitis (FPIAP) is the leading cause of rectal bleeding in infants. Tolerance is presumed to develop until the first year of age, although natural history studies are scarce, making the determination of the ideal duration for any intervention, challenging. Intestinal microbiota (IM) is crucial in food allergy development; however, data for FPIAP remain limited. This study aimed to assess FPIAP remission after 3 months of milk avoidance and its correlation with IM longitudinal changes.
A prospective observational study of infants aged ≤6 months with a diagnosis of FPIAP. After 3 months of management according to a clinical algorithm, infants were subjected to a milk challenge using either a cow (CM) or a goat (GM) milk formula in a random order. Stool samples were collected longitudinally for microbiome analysis.
Out of 61 infants, 57 were challenged (29 with CM, 28 with GM). Of these, 55 (96.5%) achieved tolerance, with no difference in tolerance rates between CM (28/29) and GM (27/28). The average age of tolerance development was 6.3 months. Enterobacteriaceae clusters (Klebsiella- and Shigella-dominated) were most often represented in samples from symptomatic infants. In contrast, Bacteroides and Bifidobacteria clusters emerged later, in apparently healthy infants.
A 3-month intervention was sufficient for almost all infants to achieve tolerance. GM was tolerated equally well to CM. Symptomatic FPIAP is associated with immature enterotypes, while disease remission coincides with microbiome changes in time.
食物蛋白诱导的过敏性直肠结肠炎(FPIAP)是婴儿直肠出血的主要原因。尽管自然史研究较少,但一般认为在一岁前会形成耐受性,这使得确定任何干预措施的理想持续时间具有挑战性。肠道微生物群(IM)在食物过敏的发展中至关重要;然而,关于FPIAP的数据仍然有限。本研究旨在评估避免食用牛奶3个月后FPIAP的缓解情况及其与IM纵向变化的相关性。
对年龄≤6个月、诊断为FPIAP的婴儿进行前瞻性观察研究。根据临床方案管理3个月后,婴儿随机依次使用牛奶配方奶(CM)或羊奶配方奶(GM)进行牛奶激发试验。纵向收集粪便样本进行微生物组分析。
61名婴儿中,57名接受了激发试验(29名使用CM,28名使用GM)。其中,55名(96.5%)获得了耐受性,CM组(28/29)和GM组(27/28)的耐受性率无差异。耐受性形成的平均年龄为6.3个月。有症状婴儿的样本中最常出现肠杆菌科菌群(以克雷伯菌属和志贺菌属为主)。相比之下,拟杆菌属和双歧杆菌属菌群在明显健康的婴儿中出现得较晚。
3个月的干预足以使几乎所有婴儿获得耐受性。GM与CM的耐受性相当。有症状的FPIAP与不成熟的肠道类型有关,而疾病缓解与微生物组随时间的变化一致。